Rituximab in pemphigus and pemphigoid patients: Treatment outcomes and safety profile - A 6-year tertiary center study. Asian J Med Sci. 2025;16(7):87-91. Accessed July 9, 2026. https://www.nepjol.info/index.php/AJMS/article/view/79086